- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRNA
Recent news which mentions MRNA
3 Stocks That Are Dead in the Water
October 19, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
From Benzinga
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
October 19, 2023
From Motley Fool
Nvidia, United Airlines, Moderna, Lucid, Bank Of America: Why These Five Stocks Are On Investors' Horizons Today
October 17, 2023
From Benzinga
What's Going On With Moderna Stock?
October 17, 2023
From Benzinga
Do These 5 Words From Pfizer Mean Trouble for Novavax?
October 17, 2023
From Motley Fool
From MarketWatch
From MarketWatch
Moderna confirms COVID sales guidance as shares sink on Pfizer news
October 16, 2023
From MarketWatch
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
October 16, 2023
From Benzinga
From Benzinga
Is Novavax Stock a Buy Now?
October 16, 2023
From Motley Fool
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
October 16, 2023
From MarketWatch
Don’t Hold On: 7 Stocks to Sell Before 2024
October 15, 2023
From InvestorPlace
Pfizer’s stock sinks after company cuts outlook on lower demand for COVID treatments
October 13, 2023
From MarketWatch
From Motley Fool
2 Top Biotech Stocks to Buy Right Now
October 12, 2023
From Motley Fool
3 Stocks That Are Down Big, But Are Due to Fall Much Further
October 12, 2023
From InvestorPlace
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
October 11, 2023
From Motley Fool
Big Pharma Could Transform Into BioTech Pharma
October 10, 2023
From Benzinga
3 Shaky Stocks to Sell in October Before It’s Too Late
October 09, 2023
From InvestorPlace
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
October 09, 2023
From Benzinga
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
October 09, 2023
From Benzinga
Intuit, Nordstrom And 2 Other Stocks Insiders Are Selling
October 09, 2023
From Benzinga
3 Pharma Stocks to Dump Before the Damage Is Done
October 08, 2023
From InvestorPlace
Rule Breaker Investing's "Market Cap Game Show" Rolls On
October 07, 2023
From Motley Fool
These 2 Top Stocks Are Screaming Buys Right Now
October 07, 2023
From Motley Fool
This Could be Novavax's Big Opportunity
October 07, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.